Pharmacokinetics and Pharmacodynamics of Methylecgonidine, a Crack Cocaine Pyrolyzate

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 3, 2003, Pages 1179-1187

  Scheidweiler, Karl B ^a,c   Plessinger, Mark A ^b   Shojaie, Jalil ^b   Wood, Ronald W ^b   Kwong, Tai C ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE METHYL BROMIDE; BIOLOGICAL MARKER; CENTRAL STIMULANT AGENT; COCAINE DERIVATIVE; ECGONIDINE; ECGONINE; ECGONINE METHYL ESTER; METHYLECGONIDINE; MUSCARINIC AGENT; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; BODY FLUID; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG HALF LIFE; FEMALE; GAS CHROMATOGRAPHY; HEART MUSCLE CELL; HEART RATE; HYPOTENSION; MASS SPECTROMETRY; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; SHEEP; SMOKING; TACHYCARDIA;

ANIMALS; ATROPINE DERIVATIVES; BLOOD PRESSURE; COCAINE; CRACK COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALF-LIFE; HEART RATE; HEMODYNAMIC PROCESSES; INDICATORS AND REAGENTS; METHACHOLINE CHLORIDE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; SHEEP;

EID: 0344304764     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.055434     Document Type: Article

References (38)

1. Bolla KI, Rothman R, and Cadet JL (1999) Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci 11:361-369.
2. Brown JH and Taylor P (1996) Muscarinic receptor agonists and antagonists, in The Pharmacological Basis of Therapeutics (Hardman J and Limbird L eds) pp 141-160, McGraw-Hill, New York.
3. Cassel JC and Kelche C (1989) Scopolamine treatment and fimbria-fornix lesions: mimetic effects on radial maze performance. Physiol Behav 46:347-353.
4. Chambers JM, Cleveland WC, Kleiner B, and Tukey PA (1983) Graphical Methods for Data Analysis. Wadsworth International Group and Duxbury Press, Boston.
5. Clarke GPY (1987) Approximate confidence limits for a parameter function in non-linear regression. J Am Stat Assoc 82:221-230.
6. Cone EJ, Hillsgrove M, and Darwin WD (1994) Simultaneous measurement of cocaine, cocaethylene, their metabolites and "crack" pyrolysis products by gas chromatography-mass spectrometry. Clin Chem 40:1299-1305.
7. Di Sclafani V, Tolou-Shams M, Price LJ, and Fein G (2002) Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and al-cohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend 66:161-171.
8. Donaldson JR and Schnabel RB (1987) Computation experience with confidence regions and confidence intervals for non-linear least squares. Technometrics 29: 67-82.
9. Erzouki HK, Allen AC, Newman AH, Goldberg SR, and Schindler CW (1995) Effects of cocaine, cocaine metabolites and cocaine pyrolysis products on the hindbrain cardiac and respiratory centers of the rabbit. Life Sci 57:1861-1868.
10. Fandino AS, Karas M, Toennes SW, and Kauert G (2002) Identification of anhydro-ecgonine methyl ester N-oxide, a new metabolite of anhydroecgonine methyl ester, using electrospray mass spectrometry. J Mass Spectrom 37:525-532.
11. Haddad el-B and Rousell J (1998) Regulation of the expression and function of the M2 muscarinic receptor. Trends Pharmacol Sci 19:322-327.
12. Huang L, Woolf JH, Ishiguro Y, and Morgan JP (1997) Effect of cocaine and methylecgonidine on intracellular Ca2+ and myocardial contraction in cardiac myocytes. Am J Physiol 273:H893-H901.
13. Jacob P 3rd, Lewis ER, Elias-Baker BA, and Jones RT (1990) A pyrolysis product, anhydroecgonine methyl ester (methylecgonidine), is in the urine of cocaine smokers. J Anal Toxicol 14:353-357.
14. Jenkins AJ and Goldberger BA (1997) Identification of unique cocaine metabolites and smoking by-products in postmortem blood and urine specimens. J Forensic Sci 42:824-827.
15. Jenkins AJ, Oyler JM, and Cone EJ (1995) Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J Anal Toxicol 19:359-374.
16. Kelly RA, Balligand JL, and Smith TW (1996) Nitric oxide and cardiac function. Circ Res 79:363-380.
17. Khan M, Gupta PK, Cristie R, Nangia A, Winter H, Lam FC, Perrier DG, and Hung CT (1987) Determination of pharmacokinetics of cocaine in sheep by liquid chromatography. J Pharm Sci 76:39-43.
18. Kintz P, Cirimele V, Sengler C, and Mangin P (1995) Testing human hair and urine for anhydroecgonine methyl ester, a pyrolysis product of cocaine. J Anal Toxicol 19:479-482.
19. Kintz P, Sengler C, Cirimele V, and Mangin P (1997) Evidence of crack use by anhydroecgonine methylester identification. Hum Exp Toxicol 16:123-127.
20. Knuepfer MM (2003) Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol Ther 97:181-222.
21. Lind L, Sarabi M, Millgard J, Kahan T, and Edner M (1999) Endothelium-dependent vasodilation and structural and functional changes in the cardiovascular system are dependent on age in healthy subjects. Clin Physiol 19:400-409.
22. Nakahara Y and Ishigami A (1991) Inhalation efficiency of free-base cocaine by pyrolysis of 'crack' and cocaine hydrochloride. J Anal Toxicol 15:105-109.
23. Paul BD, McWhorter LK, and Smith ML (1999) Electron ionization mass fragmentometric detection of urinary ecgonidine, a hydrolytic product of methylecgonidine, as an indicator of smoking cocaine. J Mass Spectrom 34:651-660.
24. Riley KJ, Lu NT, Meeker JE, Lo P, Fortner N, and Taylor BG (2001) Monitoring the crack epidemic through urine testing: establishment of routine detection methods. Addict Biol 6:83-95.
25. Rowland M and Tozer TN (1995) Clinical Pharmacokinetics: Concepts and Applications. Lippincott Williams & Wilkins, Philadelphia.
26. Saucier D, Hargreaves EL, Boon F, Vanderwolf CH, and Cain DP (1996) Detailed behavioral analysis of water maze acquisition under systemic NMDA or muscarinic antagonism: nonspatial pretraining eliminates spatial learning deficits. Behav Neurosci 110:103-116.
27. Sawyer BD, Bymaster FP, Calligaro DO, Falcone J, Mitch CH, Ward JS, Whitesitt C, and Shannon HE (1999) Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aorta. Gen Pharmacol 32:445-452.
28. Scheidweiler KB, Shojaie J, Plessinger MA, Wood RW, and Kwong TC (2000) Stability of methylecgonidine and ecgonidine in sheep plasma in vitro. Clin Chem 46:1787-1795.
29. Schwarz RD, Callahan MJ, Coughenour LL, Dickerson MR, Kinsora JJ, Lipinski WJ, Raby CA, Spencer CJ, and Tecle H (1999) Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization. J Pharmacol Exp Ther 291:812-822.
30. Shimomura ET, Hodge GD, and Paul BD (2001) Examination of postmortem fluids and tissues for the presence of methylecgonidine, ecgonidine, cocaine and benzoylecgonine using solid-phase extraction and gas chromatography-mass spectrometry. Clin Chem 47:1040-1047.
31. Toennes SW, Fandino AS, Hesse FJ, and Kauert GF (2003) Artifact production in the assay of anhydroecgonine methyl ester in serum using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 792:345-351.
32. Toennes SW, Fandino AS, and Kauert G (1999) Gas chromatographic-mass spectrometric detection of anhydroecgonine methyl ester (methylecgonidine) in human serum as evidence of recent smoking of crack. J Chromatogr B Biomed Sci Appl 735:127-132.
33. Wood RW, Shojaie J, Fang CP, and Graefe JF (1996) Methylecgonidine coats the crack particle. Pharmacol Biochem Behav 53:57-66.
34. Woolf JH, Huang L, Ishiguro Y, and Morgan JP (1997) Negative inotropic effect of methylecgonidine, a major product of cocaine base pyrolysis, on ferret and human myocardium. J Cardiovasc Pharmacol 30:352-359.
35. Xiao YF and Morgan JP (1998) Cocaine blockade of the acetylcholine-activated muscarinic K+ channel in ferret cardiac myocytes. J Pharmacol Exp Ther 284: 10-18.
36. Yamada M (2002) The role of muscarinic K(+) channels in the negative chronotropic effect of a muscarinic agonist. J Pharmacol Exp Ther 300:681-687.
37. Yang Y, Ke Q, Cai J, Xiao YF, and Morgan JP (2001) Evidence for cocaine and methylecgonidine stimulation of M(2) muscarinic receptors in cultured human embryonic lung cells. Br J Pharmacol 132:451-460.
38. Yang Y, Liao H, Ke Q, Cai J, Xiao YF, and Morgan JP (2002) Enhancement of nitric oxide production by methylecgonidine in cultured neonatal rat cardiomyocytes. Br J Pharmacol 135:188-196.